GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SSY Group Ltd (HKSE:02005) » Definitions » Beneish M-Score

SSY Group (HKSE:02005) Beneish M-Score : -2.26 (As of May. 17, 2024)


View and export this data going back to 2005. Start your Free Trial

What is SSY Group Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.26 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for SSY Group's Beneish M-Score or its related term are showing as below:

HKSE:02005' s Beneish M-Score Range Over the Past 10 Years
Min: -2.79   Med: -2.19   Max: -1.77
Current: -2.26

During the past 13 years, the highest Beneish M-Score of SSY Group was -1.77. The lowest was -2.79. And the median was -2.19.


SSY Group Beneish M-Score Historical Data

The historical data trend for SSY Group's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SSY Group Beneish M-Score Chart

SSY Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.77 -2.47 -2.11 -2.08 -2.26

SSY Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.11 - -2.08 - -2.26

Competitive Comparison of SSY Group's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, SSY Group's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SSY Group's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, SSY Group's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where SSY Group's Beneish M-Score falls into.



SSY Group Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of SSY Group for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0216+0.528 * 0.9901+0.404 * 1.0475+0.892 * 1.0045+0.115 * 1.0207
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9223+4.679 * 0.032831-0.327 * 0.9669
=-2.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was HK$2,376 Mil.
Revenue was HK$6,463 Mil.
Gross Profit was HK$3,620 Mil.
Total Current Assets was HK$5,124 Mil.
Total Assets was HK$11,966 Mil.
Property, Plant and Equipment(Net PPE) was HK$5,053 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$406 Mil.
Selling, General, & Admin. Expense(SGA) was HK$1,530 Mil.
Total Current Liabilities was HK$2,521 Mil.
Long-Term Debt & Capital Lease Obligation was HK$1,951 Mil.
Net Income was HK$1,319 Mil.
Gross Profit was HK$0 Mil.
Cash Flow from Operations was HK$926 Mil.
Total Receivables was HK$2,315 Mil.
Revenue was HK$6,434 Mil.
Gross Profit was HK$3,568 Mil.
Total Current Assets was HK$4,884 Mil.
Total Assets was HK$10,967 Mil.
Property, Plant and Equipment(Net PPE) was HK$4,517 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$371 Mil.
Selling, General, & Admin. Expense(SGA) was HK$1,651 Mil.
Total Current Liabilities was HK$2,678 Mil.
Long-Term Debt & Capital Lease Obligation was HK$1,562 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(2376.167 / 6463.009) / (2315.436 / 6434.025)
=0.367656 / 0.359874
=1.0216

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(3567.586 / 6434.025) / (3619.639 / 6463.009)
=0.554487 / 0.560055
=0.9901

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (5124.117 + 5053.112) / 11966.336) / (1 - (4884.452 + 4516.846) / 10966.512)
=0.149512 / 0.142727
=1.0475

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=6463.009 / 6434.025
=1.0045

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(370.642 / (370.642 + 4516.846)) / (405.574 / (405.574 + 5053.112))
=0.075835 / 0.074299
=1.0207

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1529.658 / 6463.009) / (1651.044 / 6434.025)
=0.236679 / 0.256611
=0.9223

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1951.327 + 2521.44) / 11966.336) / ((1561.566 + 2677.886) / 10966.512)
=0.373779 / 0.386582
=0.9669

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(1318.616 - 0 - 925.747) / 11966.336
=0.032831

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

SSY Group has a M-score of -2.26 suggests that the company is unlikely to be a manipulator.


SSY Group Beneish M-Score Related Terms

Thank you for viewing the detailed overview of SSY Group's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


SSY Group (HKSE:02005) Business Description

Traded in Other Exchanges
N/A
Address
Central Plaza, 18 Harbour Road, Rooms 4902-03, 49th Floor, Wanchai, Hong Kong, HKG
SSY Group Ltd is engaged in the research, development, manufacturing and selling of a wide range of pharmaceutical products, which includes finished medicines of mainly intravenous infusion solution and ampoule injection to hospitals and distributors, bulk pharmaceuticals and medical materials. The company has two reportable segments including intravenous infusion solution and others and medical materials. The company derives a vast majority of its revenue principally from the Intravenous infusion solution and others. Revenue generation is driven mostly by its sales of pharmaceutical products, followed by medical materials.

SSY Group (HKSE:02005) Headlines

No Headlines